Standard BioTools Inc.LABNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
5Y CAGR+12.3%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

5Y CAGR
+12.3%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202545.55%
2024-229.18%
202350.51%
2022-62.57%
2021-103.76%
202025.46%
2019-47.58%
20180.55%
201741.77%
20162.61%